≡ Pfizer Assists World Health Organization In Search For New Treatments Against Diseases Of The Developing World Part 3
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration have granted tentative sanction in espouse of the Company’s Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg, 50 mg and 100 mg. Final approval be scheduled upon expiry of credential resistance for the pour scorn […]
